Heart Failure Prevention through Cardiovascular Risk Factor Management

Introduction to Heart Failure Prevention

The American Heart Association recommends aggressive control of hypertension, type 2 diabetes, dyslipidaemia, and obesity to prevent incident heart failure, with each risk factor independently contributing to heart failure development and requiring specific evidence-based interventions 1, 2

The European Society of Cardiology recommends blood pressure control to prevent heart failure, with ACE inhibitors or ARBs as first-line therapy 3
Each 10 mmHg reduction in systolic blood pressure reduces incident heart failure risk by 17% 3
Management of systolic and diastolic hypertension reduces heart failure incidence by approximately 50% 4
ACE inhibitors and ARBs demonstrate superiority over beta-blockers, calcium channel blockers, or diuretics specifically for heart failure prevention 3

The European Association for the Study of Diabetes recommends considering metformin or SGLT2 inhibitors as first-line therapy for diabetes to prevent heart failure 3
Metformin has been consistently associated with lower rates of incident heart failure in observational studies 3
SGLT2 inhibitors reduce incident heart failure risk in both diabetic and non-diabetic patients 3
Each 1% increase in HbA1c is associated with an 8% increased risk of heart failure 5

The European Society of Cardiology recommends maintaining normal weight (BMI 20-25 kg/m²) for heart failure prevention 3
Each 1 kg/m² increase in BMI increases incident heart failure risk by 4.7% 3
Women who become obese have a 41% increased risk of incident heart failure compared to those maintaining BMI <30 kg/m² 3
Bariatric surgery in morbidly obese individuals (BMI ≥40 kg/m²) has been associated with lower incident heart failure risk 3

The American College of Cardiology recommends aggressive treatment of hyperlipidemia with statins to reduce heart failure risk in at-risk patients 4
Statins should be used to prevent symptomatic heart failure and cardiovascular events in patients with reduced ejection fraction and history of myocardial infarction 4

The European Society of Cardiology recommends maintaining an active lifestyle, with 150-300 minutes per week of moderate intensity or 75-150 minutes per week of vigorous intensity aerobic activity 3

While obesity increases incident heart failure risk, once heart failure is established, higher BMI paradoxically associates with better survival 6, 7
Targeting HbA1c <6.0% does not prevent heart failure and may cause harm 3
Focus on medication selection (metformin, SGLT2 inhibitors) rather than extremely tight glycemic targets 3
Early intervention is critical, as cardiovascular effects of obesity start early in life, even from childhood, and prevention strategies must begin before disease manifestation emerges 1, 2